04.05.2005 22:33:00
|
Millipore CFO at Baird's 2005 Growth Stock Conference on May 10th, 20
Business Editors/Medical Editors
Baird's 2005 Growth Stock Conference
BILLERICA, Mass.--(BUSINESS WIRE)--May 4, 2005--Millipore Corporation (NYSE:MIL) announced today that Kathy Allen, Millipore's Chief Financial Officer will be speaking at Baird's 2005 Growth Stock Conference on May 10th at 2:05 Eastern Time. The conference is being held at the Four Seasons Hotel in Chicago, IL. Ms. Allen's presentation will be webcast and available for viewing live and after the conference. You can access the webcast from the Millipore home page, www.millipore.com. You can also access the webcast at this web site: http://www.wsw.com/webcast/rwbaird11/mil/.
About Millipore
Millipore is a multinational bioscience company that provides technologies, tools and services for the discovery, development and production of new therapeutic drugs. It serves the life science research, biotechnology and pharmaceutical industries. For more information about Millipore visit www.millipore.com.
--30--JO/bo*
CONTACT: Millipore Corporation Investor Contact Geoffrey Helliwell, 978-715-1041 or 800-225-3384 Geoffrey_Helliwell@Millipore.com or Media Contact Thomas Anderson, 978-715-1043 or 800-225-3384 Thomas_Anderson@Millipore.com
KEYWORD: MASSACHUSETTS ILLINOIS TRACK INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL DEVICES BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: Millipore Corporation
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck KGaAmehr Nachrichten
28.11.24 |
Zuversicht in Frankfurt: LUS-DAX schlussendlich mit grünen Vorzeichen (finanzen.at) | |
28.11.24 |
Gewinne in Frankfurt: DAX schlussendlich freundlich (finanzen.at) | |
25.11.24 |
DAX 40-Wert Merck-Aktie: So viel Verlust wäre bei einem Investment in Merck von vor 3 Jahren angefallen (finanzen.at) | |
20.11.24 |
Gewinne in Frankfurt: LUS-DAX mit Zuschlägen (finanzen.at) | |
20.11.24 |
Handel in Frankfurt: DAX am Mittwochmittag fester (finanzen.at) | |
19.11.24 |
XETRA-Handel DAX verbucht zum Start des Dienstagshandels Verluste (finanzen.at) | |
19.11.24 |
Starker Wochentag in Frankfurt: LUS-DAX klettert zum Start des Dienstagshandels (finanzen.at) | |
18.11.24 |
Schwacher Handel in Frankfurt: LUS-DAX zum Handelsende leichter (finanzen.at) |
Analysen zu Merck KGaAmehr Analysen
18.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
15.11.24 | Merck Buy | Deutsche Bank AG | |
15.11.24 | Merck Buy | UBS AG | |
15.11.24 | Merck Buy | Goldman Sachs Group Inc. | |
14.11.24 | Merck Buy | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
Merck KGaA | 141,25 | 0,07% |
Indizes in diesem Artikel
S&P 500 | 6 032,38 | 0,56% |